Ophthalmic organizations, government agencies join forces to discuss clinical trial for dissatisfied LASIK patients

SAN FRANCISCO — The American Society of Cataract and Refractive Surgery and the American Academy of Ophthalmology, in conjunction with the U.S. Food and Drug Administration and the National Eye Institute, have assembled a joint task force charged with formulating a viable study design to identify dissatisfied post-LASIK patients, define their significant symptoms and evaluate the influence of those symptoms on quality of life, according to a joint press release from ASCRS and AAO.

The collaboration marks the first time that the FDA has called for counsel from external organizations concerning the design of such a study, the release said.

source: OSN Supersite